Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Comprehensive Cardiac Arrhythmia Panel PreventionGenetics, part of Exact Sciences United States | 79 | 65 |
|
Invitae Hypertrophic Cardiomyopathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 75 | 59 |
|
PRKAG2-Related Disorders via the PRKAG2 Gene PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
Glycogen storage disorder panel. 29-gene NGS panel. Genologica Medica Spain | 33 | 29 |
|
Hypoglycemia, hyperinsulinism, and ketone metabolism panel. NGS panel of 50 genes. Genologica Medica Spain | 73 | 50 |
|
Glycogenosis (inherited metabolic disorders). NGS panel of 24 genes. Genologica Medica Spain | 30 | 24 |
|
Genologica Medica Spain | 172 | 59 |
|
Glycogen Storage Disorders Panel, Sequencing ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 40 | 32 |
|
Hypertrophic Cardiomyopathy Panel, Sequencing ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 25 | 34 |
|
PRKAG2 Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 3 | 1 |
|
Arrhythmia & Cardiomyopathy Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 211 | 93 |
|
Cardiomyopathy Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 170 | 71 |
|
Cardiomyopathy Panel, Hypertrophic CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 85 | 35 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 3 | 1 |
|
Cardiomyopathy, familial hypertrophic: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 30 | 26 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Wolff-Parkinson-White Syndrome (PRKAG2 Single Gene Test) Fulgent Genetics United States | 3 | 1 |
|
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States | 177 | 59 |
|
Comprehensive Cardiomyopathy NGS Panel Fulgent Genetics United States | 450 | 128 |
|
Arrhythmogenic Right Ventricular Cardiomyopathy NGS Panel Fulgent Genetics United States | 118 | 46 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.